| 000 -LEADER |
|---|
| fixed length control field |
01693nam a2200361Ia 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ebr10606369 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
CaPaEBR |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
111220s2012 dcua sb 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9780309253154 |
|
|---|
| Cancelled/invalid ISBN |
0309253152 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
CaPaEBR |
| Transcribing agency |
CaPaEBR |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)813396119 |
| 050 14 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
R853.C55 |
| Item number |
E585 2012eb |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Envisioning a transformed clinical trials enterprise in the United States |
| Medium |
[electronic resource] : |
| Remainder of title |
establishing an agenda for 2020: workshop summary / |
| Statement of responsibility, etc |
Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Washington : |
| Name of publisher, distributor, etc |
National Academies Press, |
| Date of publication, distribution, etc |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 232 p. : |
| Other physical details |
ill. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 533 ## - REPRODUCTION NOTE |
|---|
| Type of reproduction |
Electronic reproduction. |
| Place of reproduction |
Palo Alto, Calif. : |
| Agency responsible for reproduction |
ebrary, |
| Date of reproduction |
2011. |
| Note about reproduction |
Available via World Wide Web. |
| -- |
Access may be limited to ebrary affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical trials |
| Geographic subdivision |
United States. |
|
|---|
| Topical term or geographic name as entry element |
Clinical medicine |
| General subdivision |
Research |
| Geographic subdivision |
United States. |
| 655 #7 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| Source of term |
local |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Weisfeld, Neil E. |
|
|---|
| Personal name |
English, Rebecca A. |
|
|---|
| Personal name |
Claiborne, Anne B. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Institute of Medicine (U.S.). |
| Subordinate unit |
Forum on Drug Discovery, Development, and Translation. |
|
|---|
| Corporate name or jurisdiction name as entry element |
Institute of Medicine (U.S.). |
| Subordinate unit |
Board on Health Sciences Policy. |
|
|---|
| Corporate name or jurisdiction name as entry element |
National Academies Press (U.S.) |
|
|---|
| Corporate name or jurisdiction name as entry element |
ebrary, Inc. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://site.ebrary.com/lib/kliuc/Doc?id=10606369 |
| Public note |
An electronic book accessible through the World Wide Web; click to view |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
E-book |
